Analysis

Key takeaways from Walmart’s (WMT) Q3 2025 report

Over the years, Walmart Inc. (NYSE: WMT) has followed a successful business model focused on offering customers a unique shopping experience and

What to look for when Macy’s (M) reports its Q3 2024 earnings results

Shares of Macy’s, Inc. (NYSE: M) remained red on Tuesday. The stock has dropped 14% over the past three months. The retailer

Applied Materials (AMAT) sees continued growth momentum in fiscal 2025

Applied Materials, Inc. (NASDAQ: AMAT) has reported better-than-expected fourth-quarter results, but the company's stock slipped soon after the announcement last week. The

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

MDT Earnings: Highlights of Medtronic’s Q2 2025 financial results

Medical device maker Medtronic plc (NYSE: MDT) reported a modest increase in revenues and adjusted profit for the second quarter of 2025. Second-quarter earnings, excluding special items, rose 1% year-over-year

November 19, 2024

WMT Earnings: Walmart Q3 sales and profit rise and beat estimates

Retail giant Walmart Inc. (NYSE: WMT) on Tuesday announced financial results for the third quarter of 2025, reporting an increase in sales and net profit. The numbers also topped expectations.

November 19, 2024

LOW Earnings: Key quarterly highlights from Lowe’s Q3 2024 financial results

Lowe's Companies, Inc. (NYSE: LOW) reported its third quarter 2024 earnings results today. Total sales were $20.2 billion, compared to $20.5 billion in the prior-year quarter. Comparable sales decreased 1.1%.

November 19, 2024

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top